short introduction slidedeck on our immunology focus

1. • As of the 21st of March 2016 our Company changed his
“brand” name and logo
• The logo’s and branding will be changed soon. Below you
will find our new re-presentation and logo
• Our new website can be found on www.triskelion.nl
New Company Branding

2. Triskelion and Immunology
Short intro, portfolio focus
2016

3. • Contract Research Organisation
• Commercial company, separated from TNO institute in 2011
• 220 employed scientists
• All facilities, 1 central location in The Netherlands
TNO Triskelion BV
3

4. 4
Triskelion
Toxicology
Analytical
Services
Regulatory
Services
& Risk
Evaluation
ADME/DMPK
Pharmacology
& Immunology
TNO Triskelion – Markets and Expertise

5. Immunology
Autoimmune
diseases
Multiple
Sclerosis
Psoriasis
Inflammatory
Bowel Disease
SLE
Viral
infection
Influenza
Hepatitis
RSV
Cancer
Immunotherapy
Melanoma
RCC
Prostate
Colon
Rhino
Rheumatoid Arthritis
Alzheimer
Our Immunology focus

6. 6
BREAKTHROUGH OF THE YEAR

7. CANCER IMMUNOTHERAPY FOCUS AND DEVELOPMENT
XENOGRAFT MODELS
IMMUNE DEFICIENT MOUSE
HUMAN CELL TUMOR
FULLY HUMANIZED MODELS
FULLY COMPETENT HUMAN
IMMUNE SYSTEM
FULLY COMPETENT MOUSE
IMMUNE SYSTEM
MOUSE CELL TUMOR
HUMAN TUMOR
SYNGENEIC MODELS
HUMAN PBMC
SEB_IL-2 ASSAY
HUMAN
IN VITRO MODEL

8. 8
Contact & Information
Follow us on linkedin
Visit our website (will be updated in march 2016)
http://www.tnotriskelion.com/pharma
Or call me at +31652803578 or mail
paul.stoffels@tno.triskelion.nl
This presentation is a limited version of a full slide deck with more
details we are able to share on our expertise areas
Contact us if you wish to discuss your topic of interest